Biopharmaceutical & Pharmaceutical Training & Technology, Medical Device & Biotech Training - CfPIE
email this pagequestions or commentsemail listview cart
header image header image

Courses by Type

Courses by Date

Courses by Location

Certification Programs

Client Endorsements

On-Site Training

Course Catalog

Course Locations
& Transportation


Accreditation

About Us

Press Releases

Frequently Asked
Questions


Employment
Opportunities


Suggest a Course

Site Map






Preparing the CMC Section for NDAs/INDs/CTDs


COURSE AGENDA
 
DAY ONE


ICH Process and CTD Organization
  • ICH Background/Working Groups
  • ICH 5-Step Process
  • CTD Modules
Requirements for Drug Substance

  • S.1 General Information: Nomenclature, Structure, General Properties
  • S.2 Manufacture
    • Manufacturers 
    • Description of Manufacturing Process and Process Controls
      • Flow diagram
      • Process Narrative 
      • Process Controls
    • Control of Materials
      • Starting Materials
      • Reagents, Solvents, Auxiliary Materials
    • Control of Critical Steps and Intermediates
    • Manufacturing Process Development
  • S.3 Characterization
    • Elucidation of Structure
    • Other Characteristics
      • Physicochemical properties
      • Solid State Forms
    • Impurities
      • Types (organic, inorganic, residual solvents)
      • Classification (specified/unspecified, identified/unidentified)
      • Reporting, Identification and Qualification Thresholds
      • Acceptance Criteria
      • Qualification
  • S.4 Control of the Drug Substance
    • Specifications
    • Analytical Procedures
    • Validation of Analytical Procedures
    • Batch Analyses
    • Justification for Specifications
  • S.5 Reference Standards
  • S.6 Container Closure System
  • S.7 Stability
    • Stability Protocol and Data Evaluation
    • Forced Degradation/Stress Testing
    • Photostability
    • Stability Summary and Conclusion
    • Post-approval Stability Protocol and Commitment
    • Stability Data

 

DAY TWO

Drug Master Files

  • What are they
  • Types of DMFs
  • How are they used?
  • When are they used?
  • Information in a DMF vs. NDA

Requirements for the Drug Product
  • P.1 Description and Composition
  • P.2 Pharmaceutical Development
    • Drug Substance
    • Excipients
    • Formulation Development
    • Manufacturing Process Development
    • Container Closure Suitability
  • P.3 Manufacture
    • Manufacturer
    • Batch Formula
    • Description of Manufacturing Process and Process Controls
    • Control of Critical Steps and Intermediates
  • P.4 Control of Excipients
  • P.5 Control of the Drug Product
    • Specifications (release, stability, in-house)
    • Analytical Procedures
    • Validation of Analytical Procedures
    • Batch Analyses
    • Justification of Specifications
  • P.6 Reference Standards
  • P.7 Container Closure Systems
    • Primary, Secondary, Functional and Non-Functional Secondary Packaging
  • P.8 Stability
    • Stability Protocol and Data Evaluation
    • Forced Degradation/Stress Testing
    • Photostability
    • Stability Summary and Conclusion
    • Post-approval Stability Protocol and Commitment
    • Stability Data

Regional Information

  • Executed Batch Records
  • Comparability Protocols
  • Method Validation Package
Quality Overall Summary 
  • Module 2 of CTD

FDA Interactions

  • Meetings and Preparations
  • Questions

RETURN TO COURSE DESCRIPTION



Courses by Type I Courses by Date I Courses by Location I Certification Programs I Client Endorsements
On-Site Training I Course Catalog I Course Locations & Transportation I Accreditation I About Us
Press Releases I FAQs I Employment Opportunities I Site Map I Cancellation Policy

The Center for Professional Innovation & Education®
7 Great Valley Parkway, Suite 128
Malvern, PA 19355
Phone: 610-688-1708